LCM
BVS icon

Legato Capital Management’s Bioventus BVS Stock Holding History

Legato Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Sell
16,967
-183,369
-92% -$1.75M 0.01% 654
2026
Q1 		$1.83M Buy
200,336
+62,774
+46% +$526K 0.17% 181
2025
Q4 		$1.02M Buy
137,562
+125,525
+1,043% +$902K 0.09% 350
2025
Q3 		$80.5K Hold
12,037
– – 0.01% 539
2025
Q2 		$79.7K Buy
+12,037
New +$85.4K 0.01% 538

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Legato Capital Management's BVS Position: Q2 2026 in Review

Legato Capital Management reduced its Bioventus (BVS) stake by 92% in Q2 2026, selling an estimated $1.75M and leaving 16,967 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #654.

Legato Capital Management first reported a position in BVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.83M in Q1 2026. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Legato Capital Management held 16,967 shares of Bioventus worth $160K as of Q2 2026.
  • Legato Capital Management sold 183,369 Bioventus shares in Q2 2026, an estimated $1.75M.
  • Bioventus made up 0.01% of Legato Capital Management's portfolio in Q2 2026, its #654 holding.
  • Legato Capital Management first reported a position in Bioventus in Q2 2025 and has held it in 5 quarters since.
  • Legato Capital Management's Bioventus position peaked at $1.83M in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.